Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells
Open accessAbstract
The family of ubiquitin (Ub)-specific proteases (USP) removes Ub from Ub conjugates and regulates a variety of cellular processes. The human genome contains many putative USP-encoding genes, but little is known about USP tissue distribution, pattern of expression, activity, and substrate specificity. We have used a chemistry-based functional proteomics approach to identify active USPs in normal, virus-infected, and tumor-derived human cells. Depending on tissue origin and stage of activation/differentiation, different USP activity profiles were revealed. The activity of specific USPs, including USP5, -7, -9, -13, -15, and -22, was up-regulated by mitogen activation or virus infection in normal T and B lymphocytes. UCH-L1 was highly expressed in tumor cell lines of epithelial and hematopoietic cell origin but was not detected in freshly isolated and mitogen-activated cells. Up-regulation of this USP was a late event in the establishment of Epstein–Barr virus-immortalized lymphoblastoid cell lines and correlated with enhanced proliferation, suggesting a possible role in growth transformation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Unique DUB activity is identified following EBV establishment of latency and correlates with changes in cell proliferation rates.
“Unique DUB activity was additionally identified following EBV establishment of latency and correlated with changes in cell proliferation rates.”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [145]
Activities of several DUBs are strongly upregulated in EBV-infected lymphocytes.
“By using AP of active DUBs and MS analysis, the activities of several DUBs were found to be strongly upregulated in EBV-infected lymphocytes (145).”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,216 · see citing works
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. J. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,027 · see citing works
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,018 · see citing works
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 964 · see citing works
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 947 · see citing works
The Neuron-Specific Protein PGP 9.5 Is a Ubiquitin Carboxyl-Terminal Hydrolase
Wilkinson, K. D., Lee, K., Deshpande, S. S., Duerksen-Hughes, P. J., Boss, J. M., & Pohl, J. (1989) · Science · doi:10.1126/science.2530630 · Cited by 871 · see citing works
Liu, Y., Fallon, L., Lashuel, H. A., Liu, Z., & Lansbury, P. T. (2002) · Cell · doi:10.1016/s0092-8674(02)01012-7 · Cited by 786 · see citing works
A cryptic protease couples deubiquitination and degradation by the proteasome
Yao, T., & Cohen, R. E. (2002) · Nature · doi:10.1038/nature01071 · Cited by 727 · see citing works
Jensen, D. E., Proctor, M. L., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201861 · Cited by 725 · see citing works
Chemistry-Based Functional Proteomics Reveals Novel Members of the Deubiquitinating Enzyme Family
Borodovsky, A., Ovaa, H., Kolli, N., Gan-Erdene, T., Wilkinson, K. D., Ploegh, H. L., & Kessler, B. M. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00248-x · Cited by 588 · see citing works
Self-citationUbiquitination and deubiquitination: Targeting of proteins for degradation by the proteasome
Wilkinson, K. D. (2000) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2000.0164 · Cited by 577 · see citing works
Verma, R., Chen, S., Feldman, R. M. R., Schieltz, D. M., Yates, J. R., Dohmen, R. J., & Deshaies, R. J. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.10.3425 · Cited by 540 · see citing works
Borodovsky, A., Kessler, B. M., Casagrande, R. J., Overkleeft, H. S., Wilkinson, K. D., & Ploegh, H. L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5187 · Cited by 504 · see citing works
Self-citationIntragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice
Saigoh, K., Wang, Y., Suh, J., Yamanishi, T., Sakai, Y., Kiyosawa, H., Harada, T., Ichihara, N., Wakana, S., Kikuchi, T., et al. (1999) · Nature Genetics · doi:10.1038/12647 · Cited by 501 · see citing works
Scheper, R. J., Broxterman, H. J., Scheffer, G. L., Kaaijk, P., Dalton, W. S., van Heijningen, T. H. M., van Kalken, C. K., Slovak, M. L., de Vries, E. G. E., & van der Valk, P. (1993) · PubMed · Cited by 493 · see citing works
Substrate Specificity of Deubiquitinating Enzymes: Ubiquitin C-Terminal Hydrolases
Larsen, C. N., Krantz, B. A., & Wilkinson, K. D. (1998) · Biochemistry · doi:10.1021/bi972274d · Cited by 391 · see citing works
Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron
Osaka, H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg211 · Cited by 363 · see citing works
The ins and outs of APC and β‐catenin nuclear transport
Henderson, B. R., & Fagotto, F. (2002) · EMBO Reports · doi:10.1093/embo-reports/kvf181 · Cited by 287 · see citing works
Otubains: a new family of cysteine proteases in the ubiquitin pathway
Balakirev, M. Y., Tcherniuk, S. O., Jaquinod, M., & Chroboczek, J. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor824 · Cited by 277 · see citing works
Vaults Are Up-regulated in Multidrug-resistant Cancer Cell Lines
Kickhoefer, V. A., Rajavel, K. S., Scheffer, G. L., Dalton, W. S., Scheper, R. J., & Rome, L. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8971 · Cited by 248 · see citing works
Wing, S. S. (2003) · International Journal of Biochemistry and Cell Biology · doi:10.1016/s1357-2725(02)00392-8 · Cited by 204 · see citing works
Brichory, F., Beer, D., Naour, F. L., Giordano, T. J., & Hanash, S. (2001) · PubMed · Cited by 203 · see citing works
UBPY: a growth‐regulated human ubiquitin isopeptidase
Naviglio, S., Matteucci, C., Matoskova, B., Nagase, T., Nomura, N., Fiore, P. P. D., & Draetta, G. F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3241 · Cited by 193 · see citing works
The fat facets gene is required for Drosophila eye and embryo development
Fischer-Vize, J. A., Rubin, G. M., & Lehmann, R. (1992) · Development · doi:10.1242/dev.116.4.985 · Cited by 191 · see citing works
DUB-1, a deubiquitinating enzyme with growth-suppressing activity.
Zhu, Y., Carroll, M. P., Papa, F. R., Hochstrasser, M., & D’Andrea, A. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3275 · Cited by 164 · see citing works
Gonen, H., Smith, C. E., Siegel, N. R., Kahana, C., Merrick, W. C., Chakraburtty, K., Schwartz, A. L., & Ciechanover, A. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7648 · Cited by 163 · see citing works
A Novel Type of Deubiquitinating Enzyme
Evans, P. C., Smith, T., Lai, M.-J., Williams, M., Burke, D. F., Heyninck, K., Kreike, M., Beyaert, R., Blundell, T. L., & Kilshaw, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301863200 · Cited by 161 · see citing works
PGP9.5 as a prognostic factor in pancreatic cancer.
Tezel, E., Hibi, K., Nagasaka, T., & Nakao, A. (2000) · PubMed · Cited by 139 · see citing works
The deubiquitinating enzyme Fam interacts with and stabilizes β‐catenin
Taya, S., Yamamoto, T. G., Kanai‐Azuma, M., Wood, S. A., & Kaibuchi, K. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00297.x · Cited by 135 · see citing works
Regulation of leukemic cell adhesion, proliferation, and survival by β-catenin
Chung, E. J., Hwang, S., Nguyen, P., Lee, S., Kim, J.-S., Kim, J. W., Henkart, P. A., Bottaro, D. P., Soon, L., Bonvini, P., et al. (2002) · Blood · doi:10.1182/blood.v100.3.982 · Cited by 131 · see citing works
c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells
Gavioli, R., Frisan, T., Vertuani, S., Bornkamm, G. W., & Masucci, M. G. (2001) · Nature Cell Biology · doi:10.1038/35060076 · Cited by 122 · see citing works
Self-citationLi, Z., Wang, D., Na, X., Schoen, S. R., Messing, E. M., & Wu, G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00534-x · Cited by 119 · see citing works
DUB-2 Is a Member of a Novel Family of Cytokine-inducible Deubiquitinating Enzymes
Zhu, Y., Lambert, K., Corless, C. N., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., & D’Andrea, A. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.51 · Cited by 112 · see citing works
Song, J. Y., Lim, J. W., Kim, H., Morio, T., & Kim, K. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303692200 · Cited by 99 · see citing works
The Oncogenicity of Epstein-Barr Virus
Miller, G. (1974) · The Journal of Infectious Diseases · doi:10.1093/infdis/130.2.187 · Cited by 94 · see citing works
Elevated expression of Unph, a proto-oncogene at 3p21.3, in human lung tumors
Gray, D. A. (1995) · Lung Cancer · doi:10.1016/0169-5002(96)84243-7 · Cited by 92 · see citing works
Spataro, V. J., Toda, T., Craig, R., Seeger, M., Dubiel, W., Harris, A. L., & Norbury, C. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30470 · Cited by 85 · see citing works
Sasaki, H. (2001) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hye113 · Cited by 53 · see citing works
Stein, U., Jürchott, K., Schläfke, M., & Hohenberger, P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.003 · Cited by 44 · see citing works
Finch, J. S., John, T. S., Krieg, P., Bonham, K., Smith, H. T., Fried, V. A., & Bowden, G. T. (1992) · PubMed · Cited by 44 · see citing works
Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.
Filipits, M., Drach, J. W., Pohl, G., Schuster, J., Stranzl, T., Ackermann, J., Königsberg, R., Kaufmann, H., Gisslinger, H., Huber, H. P., et al. (1999) · PubMed · Cited by 44 · see citing works
Janssen, J. W. G., Schleithoff, L., Bartram, C. R., & Schulz, A. (1998) · Oncogene · doi:10.1038/sj.onc.1201695 · Cited by 39 · see citing works
Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas.
Filipits, M., Jaeger, U., Simonitsch, I., Chizzali-Bonfadin, C., Heinzl, H., & Pirker, R. (2000) · PubMed · Cited by 31 · see citing works
Yanagisawa, T., Sasahara, Y., Fujie, H., Ohashi, Y., Minegishi, M., Itano, M., Morita, S., Tsuchiya, S., Hayashi, Y., Ohi, R., et al. (1998) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.184.229 · Cited by 25 · see citing works
Identification of two proteins, S14 and UIP1, that interact with UCH37
Li, T., Duan, W., Yang, H., Lee, M.-K., Mustafa, F. B., Lee, B.-H., & Teo, T.-S. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02436-4 · Cited by 25 · see citing works
Characterization of the ubiquitin-specific protease activity of the mouse/human Unp/Unph oncoprotein
Gilchrist, C. A., & Baker, R. T. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00134-5 · Cited by 25 · see citing works
Schumacher, U., Mitchell, B., & KAISERLING, E. (1994) · DNA and Cell Biology · doi:10.1089/dna.1994.13.839 · Cited by 24 · see citing works
The immunolocalization of PGP 9.5 in normal human kidney and renal cell carcinoma.
D’Andrea, V., Malinovský, L., Berni, A., Biancari, F., Biassoni, L., Matteo, F. M. D., Corbellini, L., Falvo, L., Santoni, F., Spyrou, M., et al. (1997) · PubMed · Cited by 19 · see citing works
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Deubiquitylating enzymes and drug discovery: emerging opportunities
Harrigan, J. A., Jacq, X., Martin, N. M., & Jackson, S. P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.152 · Cited by 940 · see citing works
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Chen, D., Frezza, M., Schmitt, S. M., Kanwar, J., & Dou, Q. P. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794519752 · Cited by 796 · see citing works
Mechanism-Based Profiling of Enzyme Families
Evans, M. J., & Cravatt, B. F. (2006) · Chemical Reviews · doi:10.1021/cr050288g · Cited by 568 · see citing works
Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes
Altun, M., Kramer, H., Willems, L. I., McDermott, J. L., Leach, C. A., Goldenberg, S. J., Kumar, S., Konietzny, R., Fischer, R., Kogan, E., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.08.018 · Cited by 401 · see citing works
Self-citationKapuria, V., Peterson, L. F., Fang, D., Bornmann, W. G., Talpaz, M., & Donato, N. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1530 · Cited by 383 · see citing works
Ubiquitination, Ubiquitin-like Modifiers, and Deubiquitination in Viral Infection
Isaacson, M. K., & Ploegh, H. L. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.012 · Cited by 281 · see citing works
Self-citationDiscovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.
Reverdy, C., Conrath, S., Lopez, R., Planquette, C., Atmanene, C., Collura, V., Harpon, J., Battaglia, V., Vivat, V., Sippl, W., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.02.007 · Cited by 270 · see citing works
Meulmeester, E., Maurice, M. M., Boutell, C., Teunisse, A. F. A. S., Ovaa, H., Abraham, T. E., Dirks, R. W., & Jochemsen, A. G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.024 · Cited by 260 · see citing works
Self-citationHussain, S., Zhang, Y., & Galardy, P. J. (2009) · Cell Cycle · doi:10.4161/cc.8.11.8739 · Cited by 257 · see citing works
Self-citationUSP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses
Zou, Q., Jin, J., Hu, H., Li, H. S., Romano, S., Xiao, Y., Nakaya, M., Zhou, X., Cheng, X., Yang, P., et al. (2014) · Nature Immunology · doi:10.1038/ni.2885 · Cited by 248 · see citing works
Targeting Cell Death: Pyroptosis, Ferroptosis, Apoptosis and Necroptosis in Osteoarthritis
Yang, J., Hu, S., Bian, Y., Yao, J., Wang, D., Liu, X., Guo, Z., Zhang, S., & Peng, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.789948 · Cited by 244 · see citing works
Activity-based probes as a tool for functional proteomic analysis of proteases
Fonovič, M., & Bogyo, M. S. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.5.721 · Cited by 234 · see citing works
Mechanisms, biology and inhibitors of deubiquitinating enzymes
Love, K. R., Catic, A., Schlieker, C. D., & Ploegh, H. L. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.43 · Cited by 211 · see citing works
Self-citationWeighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics
Kirkpatrick, D. S., Denison, C., & Gygi, S. P. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-750 · Cited by 209 · see citing works
Rajkumar, R., Konishi, K., Richards, T. J., Ishizawar, D. C., Wiechert, A. C., Kaminski, N., & Ahmad, F. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00254.2009 · Cited by 198 · see citing works
Structure of the Ubiquitin Hydrolase UCH-L3 Complexed with a Suicide Substrate
Misaghi, S., Galardy, P. J., Meester, W. J. N., Ovaa, H., Ploegh, H. L., & Gaudet, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410770200 · Cited by 193 · see citing works
Self-citationAdvances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors
Schauer, N. J., Magin, R. S., Liu, X., Doherty, L. M., & Buhrlage, S. J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01138 · Cited by 183 · see citing works
Gao, G., & Luo, H. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-144 · Cited by 168 · see citing works
A Deubiquitinating Activity Is Conserved in the Large Tegument Protein of the Herpesviridae
Schlieker, C. D., Korbel, G. A., Kattenhorn, L. M., & Ploegh, H. L. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15582-15585.2005 · Cited by 150 · see citing works
Self-citationBazzaro, M., Lee, M. K., Zoso, A., Stirling, W. L. H., Santillan, A., Shih, I., & Roden, R. B. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2321 · Cited by 146 · see citing works
van Gent, M., Braem, S., de Jong, A., Delagic, N., Peeters, J. G. C., Boer, I. G. J., Moynagh, P. N., Kremmer, E., Wiertz, E. J. H. J., Ovaa, H., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003960 · Cited by 145 · see citing works
Self-citationDeng, S., Zhou, H., Xiong, R., Lu, Y., Yan, D., Xing, T., Dong, L., Tang, E., & Yang, H. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9393-7 · Cited by 145 · see citing works
Characterization of the ubiquitin–proteasome system in bortezomib-adapted cells
Rückrich, T., Kraus, M., Gogel, J., Beck, A., Ovaa, H., Verdoes, M., Overkleeft, H. S., Kalbacher, H., & Driessen, C. (2009) · Leukemia · doi:10.1038/leu.2009.8 · Cited by 139 · see citing works
Self-citationTargeting ubiquitin specific proteases for drug discovery
Daviet, L., & Colland, F. (2007) · Biochimie · doi:10.1016/j.biochi.2007.09.013 · Cited by 139 · see citing works
Hussain, S., Foreman, O., Perkins, S. L., Witzig, T. E., Miles, R. R., van Deursen, J., & Galardy, P. J. (2010) · Leukemia · doi:10.1038/leu.2010.138 · Cited by 135 · see citing works
Self-citationHowell, V. M., Gill, A. J., Clarkson, A., Nelson, A. E., Dunne, R. A., Delbridge, L., Robinson, B. G., Teh, B. T., Gimm, O., & Marsh, D. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1740 · Cited by 134 · see citing works
To cell cycle, swing the APC/C
van Leuken, R. J., Clijsters, L., & Wolthuis, R. M. F. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.002 · Cited by 131 · see citing works
The therapeutic potential of deubiquitinating enzyme inhibitors
Colland, F. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380137 · Cited by 124 · see citing works
USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1
Villeneuve, N. F., Tian, W., Wu, T., Sun, Z., Lau, A., Chapman, E., Fang, D., & Zhang, D. D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.04.022 · Cited by 120 · see citing works
Hewings, D. S., Flygare, J. A., Bogyo, M. S., & Wertz, I. E. (2017) · FEBS Journal · doi:10.1111/febs.14039 · Cited by 114 · see citing works
Schlieker, C. D., Weihofen, W. A., Frijns, E., Kattenhorn, L. M., Gaudet, R., & Ploegh, H. L. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.033 · Cited by 117 · see citing works
Self-citationActivity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines
Rolén, U., Kobzeva, V., Gasparjan, N., Ovaa, H., Winberg, G., Kisseljov, F. L., & Masucci, M. G. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20177 · Cited by 111 · see citing works
Self-citationActivity‐Based Probes for the Study of Proteases: Recent Advances and Developments
Serim, S., Haedke, U., & Verhelst, S. H. L. (2012) · ChemMedChem · doi:10.1002/cmdc.201200057 · Cited by 108 · see citing works
Butterworth, M. B., Edinger, R. S., Ovaa, H., Burg, D., Johnson, J. P., & Frizzell, R. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707989200 · Cited by 107 · see citing works
Self-citationDeubiquitylating Enzymes in Cancer and Immunity
Ren, J., Yu, P., Liu, S., Li, R., Niu, X., Chen, Y., Zhang, Z., Zhou, F., & Zhang, L. (2023) · Advanced Science · doi:10.1002/advs.202303807 · Cited by 107 · see citing works
Wang, J., Loveland, A. N., Kattenhorn, L. M., Ploegh, H. L., & Gibson, W. (2006) · Journal of Virology · doi:10.1128/jvi.00401-06 · Cited by 102 · see citing works
Self-citationLiu, Y., Yang, Y., Xu, H., & Dong, X. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21802 · Cited by 102 · see citing works
Mulder, M. P. C., Oualid, F. E., ter Beek, J., & Ovaa, H. (2014) · ChemBioChem · doi:10.1002/cbic.201402012 · Cited by 96 · see citing works
Self-citationChemical and semisynthetic approaches to study and target deubiquitinases
Gopinath, P., Ohayon, S., Nawatha, M., & Brik, A. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00083e · Cited by 96 · see citing works
Dissecting the ubiquitin pathway by mass spectrometry
Xu, P., & Peng, J. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.09.004 · Cited by 91 · see citing works
The ubiquitin specific protease 4 (USP4) is a new player in the Wnt signalling pathway
Zhao, B., Schlesiger, C., Masucci, M. G., & Lindsten, K. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00682.x · Cited by 90 · see citing works
Self-citationLove, K. R., Pandya, R. K., Spooner, E., & Ploegh, H. L. (2009) · ACS Chemical Biology · doi:10.1021/cb9000348 · Cited by 90 · see citing works
Self-citationNasheri, N., Joyce, M., Rouleau, Y., Yang, P., Yao, S. Q., Tyrrell, D. L., & Pezacki, J. P. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.03.014 · Cited by 88 · see citing works
Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes
Hewings, D. S., Heideker, J., Ma, T. P., AhYoung, A. P., Oualid, F. E., Amore, A., Costakes, G. T., Kirchhofer, D., Brasher, B. B., Pillow, T. H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03511-6 · Cited by 85 · see citing works
Activity‐Based Protein Profiling: New Developments and Directions in Functional Proteomics
Uttamchandani, M., Li, J., Sun, H., & Yao, S. Q. (2008) · ChemBioChem · doi:10.1002/cbic.200700755 · Cited by 82 · see citing works
Hussain, S., Feldman, A. L., Das, C., Ziesmer, S. C., Ansell, S. M., & Galardy, P. J. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01389-12 · Cited by 79 · see citing works
Self-citationThe deubiquitinase USP21 stabilizes MEK2 to promote tumor growth
Li, W., Cui, K., Prochownik, E. V., & Li, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0523-z · Cited by 80 · see citing works
Application of activity-based probes to the study of enzymes involved in cancer progression
Paulick, M. G., & Bogyo, M. S. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.001 · Cited by 78 · see citing works
The Ubiquitin-Specific Peptidase USP15 Regulates Human Papillomavirus Type 16 E6 Protein Stability
Vos, R. M., Altreuter, J., White, E. A., & Howley, P. M. (2009) · Journal of Virology · doi:10.1128/jvi.00605-09 · Cited by 77 · see citing works
USP7 Inhibition Alleviates H2O2-Induced Injury in Chondrocytes via Inhibiting NOX4/NLRP3 Pathway
Liu, G., Liu, Q.-B., Yan, B., Zhu, Z.-Q., & Xu, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.617270 · Cited by 71 · see citing works
Hemelaar, J., Galardy, P. J., Borodovsky, A., Kessler, B. M., Ploegh, H. L., & Ovaa, H. (2004) · Journal of Proteome Research · doi:10.1021/pr0341080 · Cited by 75 · see citing works
Self-citationShahab Uddin, M. S., Ahmed, M., Bavi, P. P., El-Sayed, R., Al-Sanea, N. A., Abduljabbar, A. S., Ashari, L. H. S., Alhomoud, S. J., Al‐Dayel, F., Hussain, A. R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6109 · Cited by 72 · see citing works
Unraveling the Complexity of Ubiquitin Signaling
Strieter, E. R., & Korasick, D. A. (2011) · ACS Chemical Biology · doi:10.1021/cb2004059 · Cited by 71 · see citing works
Deubiquitination in virus infection
Lindner, H. A. (2007) · Virology · doi:10.1016/j.virol.2006.12.035 · Cited by 69 · see citing works
Jahan, A. S., Biquand, É., Muñoz-Moreno, R., Quang, A. L., Mok, C. K. P., Wong, H. H., Teo, Q. W., Valkenburg, S. A., Chin, A. W. H., Poon, L. L. M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.015 · Cited by 68 · see citing works
The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology
Greco, T. M., Diner, B. A., & Cristea, I. M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085527 · Cited by 67 · see citing works
Popp, M. W., Artavanis‐Tsakonas, K., & Ploegh, H. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807172200 · Cited by 66 · see citing works
Self-citationProtein Engineering in the Ubiquitin System: Tools for Discovery and Beyond
Zhao, B., Tsai, Y. C., Jin, B., Wang, B., Wang, Y., Zhou, H., Carpenter, T., Weissman, A. M., & Yin, J. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015651 · Cited by 65 · see citing works
Kowalski, J. R., Dahlberg, C. L., & Juo, P. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4765-10.2011 · Cited by 64 · see citing works
Ubiquitin editing enzyme UCH L1 and microtubule dynamics: Implication in mitosis
Bheda, A., Gullapalli, A., Caplow, M., Pagano, J. S., & Shackelford, J. (2010) · Cell Cycle · doi:10.4161/cc.9.5.10934 · Cited by 64 · see citing works
Genomics and proteomics approaches to the study of cancer-stroma interactions
Rodrigues‐Lisoni, F. C., Peitl, P., Vidotto, A., Polachini, G. M., Maniglia, J. V., Carmona-Raphe, J., da Cunha, B. R., Henrique, T., Souza, C. F., Teixeira, R. S. V., et al. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-14 · Cited by 63 · see citing works
Tumor Viruses and Cell Signaling Pathways: Deubiquitination versus Ubiquitination
Shackelford, J., & Pagano, J. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5089-5093.2004 · Cited by 64 · see citing works
Reversible ubiquitination regulates the Smad/TGF-β signalling pathway
Wicks, S. J., Grocott, T., Haros, K., Maillard, M., ten Dijke, P., & Chantry, A. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340761 · Cited by 62 · see citing works
Seliger, B., Fedorushchenko, A., Brenner, W., Ackermann, A., Atkins, D., Hanash, S., & Lichtenfels, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0824 · Cited by 62 · see citing works
Ward, S. J., Gratton, H. E., Indrayudha, P., Michavila, C., Mukhopadhyay, R., Maurer, S. K., Caulton, S. G., Emsley, J., & Dreveny, I. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003857 · Cited by 61 · see citing works
Comprehensive Landscape of Active Deubiquitinating Enzymes Profiled by Advanced Chemoproteomics
Pinto-Fernández, A., Davis, S. A., Schofield, A. B., Scott, H. C., Zhang, P., Salah, E., Mathea, S., Charles, P. D., Damianou, A., Bond, G. L., et al. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00592 · Cited by 61 · see citing works
Self-citationRepurposing Brigatinib for the Treatment of Colorectal Cancer Based on Inhibition of ER-phagy
Zhang, Z., Gao, W. Q., Zhou, L., Chen, Y., Qin, S., Zhang, L., Liu, J., He, Y., Lei, Y., Chen, H., et al. (2019) · Theranostics · doi:10.7150/thno.36254 · Cited by 60 · see citing works
Phillips, C. I., & Bogyo, M. S. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00554.x · Cited by 60 · see citing works
Activity-based proteomics: enzymatic activity profiling in complex proteomes
Schmidinger, H., Hermetter, A., & Birner‐Gruenberger, R. (2006) · Amino Acids · doi:10.1007/s00726-006-0305-2 · Cited by 59 · see citing works
Zhang, Y., Zhou, C.-J., Zhou, Z., Song, A., & Hu, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029362 · Cited by 58 · see citing works
Proteomic insights into ubiquitin and ubiquitin-like proteins
Denison, C., Kirkpatrick, D. S., & Gygi, S. P. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.10.010 · Cited by 57 · see citing works
Zhang, C., Cai, T., Zhu, H., Yang, L., Jiang, H., Dong, X., Hu, Y., Lin, N.-M., He, Q., & Yang, B. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1091 · Cited by 56 · see citing works
Cracking the Ubiquitin Code: The Ubiquitin Toolbox
Mulder, M. P. C., Witting, K. F., & Ovaa, H. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.037.001 · Cited by 57 · see citing works
Self-citationGlobal approaches to understanding ubiquitination.
Kaiser, P., & Huang, L. (2005) · Genome biology · doi:10.1186/gb-2005-6-10-233 · Cited by 54 · see citing works
Positive Reciprocal Regulation of Ubiquitin C-Terminal Hydrolase L1 and β-Catenin/TCF Signaling
Bheda, A., Yue, W., Gullapalli, A., Whitehurst, C. B., Liu, R., Pagano, J. S., & Shackelford, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005955 · Cited by 53 · see citing works
Hussain, S., Bedekovics, T., Liu, Q., Hu, W., Jeon, H., Johnson, S. H., Vasmatzis, G., May, D. G., Roux, K. J., & Galardy, P. J. (2018) · Blood · doi:10.1182/blood-2018-05-848515 · Cited by 50 · see citing works
Self-citationKabuta, T., Mitsui, T., Takahashi, M., Fujiwara, Y., Kabuta, C., Konya, C., Tsuchiya, Y., Hatanaka, Y., Uchida, K., Hohjoh, H., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435701 · Cited by 49 · see citing works
Bedekovics, T., Hussain, S., Feldman, A. L., & Galardy, P. J. (2015) · Blood · doi:10.1182/blood-2015-07-656678 · Cited by 48 · see citing works
Self-citationRecent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors
Li, P., & Liu, H.-M. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112107 · Cited by 48 · see citing works
Kapuria, V., Peterson, L. F., Showalter, H. D., Kirchhoff, P. D., Talpaz, M., & Donato, N. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.012 · Cited by 46 · see citing works
Dahlberg, C. L., & Juo, P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.507541 · Cited by 45 · see citing works
Active-site directed probes to report enzymatic action in the ubiquitin proteasome system
Ovaa, H. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2128 · Cited by 45 · see citing works
Self-citationProbing small molecule–protein interactions: A new perspective for functional proteomics
Lenz, T., Fischer, J. J., & Dreger, M. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.07.017 · Cited by 44 · see citing works
Solution Structure of the Human Ubiquitin-specific Protease 15 DUSP Domain
de Jong, R. N., Eiso, A. B., Diercks, T., Truffault, V., Daniëls, M., Kaptein, R., & Folkers, G. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510993200 · Cited by 44 · see citing works
UCHL1is a biomarker of aggressive multiple myeloma required for disease progression
Hussain, S., Bedekovics, T., Chesi, M., Bergsagel, P. L., & Galardy, P. J. (2015) · Oncotarget · doi:10.18632/oncotarget.5727 · Cited by 40 · see citing works
Self-citationMultiple components of the spliceosome regulate Mcl1 activity in neuroblastoma
Laetsch, T. W., Liu, X., Vu, A. T., Sliozberg, M., Vido, M. J., Elci, O. U., Goldsmith, K. C., & Hogarty, M. D. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.40 · Cited by 40 · see citing works
Gonzalez-Hernandez, M. J., Pal, A., Gyan, K. E., Charbonneau, M., Showalter, H. D., Donato, N. J., O’Riordan, M. X., & Wobus, C. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094491 · Cited by 37 · see citing works
Proteomics of Human Body Fluids
Thongboonkerd, V. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-432-2 · Cited by 67 · see citing works
Coombs, N., Sompallae, R. R., Olbermann, P., Gastaldello, S., Göppel, D., Masucci, M. G., & Josenhans, C. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.09.004 · Cited by 36 · see citing works
Self-citationCutts, A., Soond, S. M., Powell, S. J., & Chantry, A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.12.018 · Cited by 34 · see citing works
Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLC
Cao, Y., Wei, M., Li, B., Liu, Y., Lü, Y., Tang, Z., Lu, T., Yin, Y., Qin, Z., & Xu, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.8168 · Cited by 34 · see citing works
Su, Z., Cao, J.-S., Wu, Y., Chen, W.-N., Lin, X., Wu, Y., & Lin, X. (2017) · Scientific Reports · doi:10.1038/srep40246 · Cited by 33 · see citing works
Li, J., OLSON, L. M., Zhang, Z., Li, L., Bidder, M., Nguyen, L., Pfeifer, J. D., & Rader, J. S. (2008) · International Journal of Medical Sciences · doi:10.7150/ijms.5.133 · Cited by 33 · see citing works
Kobayashi, E., Aga, M., Kondo, S., Whitehurst, C. B., Yoshizaki, T., Pagano, J. S., & Shackelford, J. (2018) · mSphere · doi:10.1128/msphere.00030-18 · Cited by 32 · see citing works
Cao, M.-N., Zhou, Y., Gao, A., Cao, J., Gao, L., Li, S., Xu, L., Su, M., Cao, X., Han, M., et al. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.02.006 · Cited by 31 · see citing works
Kramer, H., Nicholson, B., Kessler, B. M., & Altun, M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.014 · Cited by 31 · see citing works
Self-citationActivity-based protein profiling of host–virus interactions
Blais, D. R., Nasheri, N., McKay, C. S., Legault, M. C. B., & Pezacki, J. P. (2011) · Trends in biotechnology · doi:10.1016/j.tibtech.2011.08.001 · Cited by 30 · see citing works
Kobayashi, E., Hwang, D., Bheda-Malge, A., Whitehurst, C. B., Kabanov, A. V., Kondo, S., Aga, M., Yoshizaki, T., Pagano, J. S., Sokolsky‐Papkov, M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153733 · Cited by 30 · see citing works
Hussain, A. R., Ahmed, M., Ahmed, S. O., Althari, S., Khan, A. S., Razack, S., Platanias, L. C., Al-Kuraya, K. S., & Shahab Uddin, M. S. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190902951799 · Cited by 30 · see citing works
Rubio, A. J., Bencomo-Alvarez, A. E., Young, J. E., Velazquez, V. V., Lara, J. J., Gonzalez, M. A., & Eiring, A. M. (2021) · Cells · doi:10.3390/cells10092390 · Cited by 29 · see citing works
- Authors
- Ovaa, H., Kessler, B. M., Rolén, U., Galardy, P. J., Ploegh, H. L., & Masucci, M. G.
- Affiliations
- Harvard University (US)
- Corresponding author
- Masucci, Maria G.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-02-11
- Volume
- 101
- Issue
- 8
- Pages
- 2253-2258
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC356937
- OpenAlex
- W2130935241
- Cited by
- 190
- References
- 49
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 5 · 2019: 11 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 7 · 2014: 13 · 2013: 7 · 2012: 9
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Multiple Myeloma Research Foundation
- Stiftelsen för Strategisk Forskning
- Cancerfonden
- Karolinska Institutet
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- ubiquitin-specific protease, deubiquitination, virus-infected cells, cancer cell lines, Epstein-Barr virus, UCHL1, USP5, USP7, USP13, USP15, USP22, lymphocyte activation, mitogen stimulation, cell proliferation, growth transformation, functional proteomics
- MeSH terms
- Ubiquitin-Specific Peptidase 7, B-Lymphocytes, Cell Line, Humans, Endopeptidases, Mass Spectrometry, T-Lymphocytes, Ubiquitin Thiolesterase, Cell Line, Tumor, Ubiquitin-Specific Proteases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review